Ronald Chandler, Ph.D., is the recipient of the 2016 Mary Kay Foundation Cancer Grant.

image001The title of his project is SWI/SNF chromatin remodeling and Pl3-kinase pathway crosstalk mechanisms in ovarian cancer. Dr. Chandler aims to identify the mechanism of ARID1A-PIK3CA functional cooperatively in endometriosis-associated ovarian cancers. His research will help to identify signaling pathway co-dependencies and drug targets in ovarian cancers with limited therapeutic options. (view biography)